aztreonam and Itching studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Research Excerpts

Excerpt	Relevance	Reference
"Aztreonam (AZT) (2 g daily) was intravenously administered for 5 to 7 days to 65 patients with complicated urinary tract infections (UTI)."	9.06	[Clinical efficacy of aztreonam in patients with complicated urinary tract infections]. ( Kageyama, Y; Kobayashi, N; Kura, N; Nakame, Y; Negishi, T; Saitoh, H; Suwata, J; Uchijima, Y; Yamada, T; Yoshida, K, 1988)
"Aztreonam (AZT) (2 g daily) was intravenously administered for 5 to 7 days to 65 patients with complicated urinary tract infections (UTI)."	5.06	[Clinical efficacy of aztreonam in patients with complicated urinary tract infections]. ( Kageyama, Y; Kobayashi, N; Kura, N; Nakame, Y; Negishi, T; Saitoh, H; Suwata, J; Uchijima, Y; Yamada, T; Yoshida, K, 1988)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

aztreonam and Itching

Research Excerpts

Research

Studies (1)

Authors

Trials

Authors	Studies
Yoshida, K	1
Uchijima, Y	1
Kobayashi, N	1
Suwata, J	1
Nakame, Y	1
Saitoh, H	1
Negishi, T	1
Yamada, T	1
Kageyama, Y	1
Kura, N	1